STAAR Surgical Company

Equities

STAA

US8523123052

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2026-01-16 pm EST			5-day change	1st Jan Change
20.97 ^USD	0.00%		-5.20%	-9.18%

Jan. 16	Staar Surgical Company Announces Board and Committee Changes, Effective January 15, 2026	CI
Jan. 15	STAAR Surgical Chair, CEO Step Down From Board as Part of Cooperation Agreement With Broadwood	MT

Yunqi Capital Comments on STAAR Surgical?s Go-Shop Process

Published on 12/10/2025 at 10:21 am EST

S&P Capital IQ

STAAR Surgical Company

0.00%

Alcon Inc.

+0.35%

On December 10, 2025, Yunqi Capital Limited announced that it has sent a letter with shareholders of STAAR Surgical Company, regarding the closing of Company?s go-shop period and the revised offer of Alcon Inc, to acquire the Company for $30.75 per share, believes the Company should not be sold now; the company is at a strategic rebound point. In addition, Yunqi Capital stating that the Company?s 30-day go-shop period was too short and structured to favor Alcon rather than attract other bidders, Alcon retained rights to review superior proposals, discouraging alternative bidders, and the Company imposed restrictive NDA terms, deterring credible buyers. Further, Yunqi Capital stating that the Company is recovering from past challenges, Company?s recent results show improving demand and operational momentum, it argues that the premium offered (74% over 90-day VWAP) is misleading without considering long-term growth potential.

Yunqi Capital urged the Company shareholders to vote against the merger and suggesting that Company?s board has lost credibility and should have pursued a full strategic review instead of a constrained process.

Stocks mentioned in the article

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	STAAR SURGICAL COMPANY	20.97USD	0.00%	-5.20%	1.04B
	ALCON INC.	63.96CHF	+0.35%	+0.41%	39.15B

Latest news about STAAR Surgical Company

Jan. 16	Staar Surgical Company Announces Board and Committee Changes, Effective January 15, 2026	CI
Jan. 15	STAAR Surgical Chair, CEO Step Down From Board as Part of Cooperation Agreement With Broadwood	MT
Jan. 15	STAAR Surgical Company Announces Board Changes, Effective January 15, 2026	CI
Jan. 15	STAAR Surgical Company Announces Stephen Farrell Steps Down as CEO, Effective January 31, 2026	CI
Jan. 15	Staar Surgical CEO to exit as part of deal with top shareholder	RE
Jan. 15	Staar Surgical and Broadwood Partners enter into cooperation agreement	RE
Jan. 07	Alcon Terminates Merger Deal With STAAR Surgical	MT
Jan. 07	Alcon terminates agreement to acquire STAAR Surgical	RE
Jan. 07	Swiss stocks - Factors to watch on January 7	RE
Jan. 06	Alcon Scraps Takeover Plans for US-based Staar Surgical	MT
Jan. 06	STAAR Surgical Company Shareholders Reject Merger Proposal with Alcon Research, LLC	CI
Jan. 06	STAAR Surgical Company Shareholders Reject Merger Proposal with Alcon Research	CI
Jan. 06	STAAR Surgical Company Shareholders Reject Merger Proposal with Alcon Research	CI
Jan. 06	Sector Update: Health Care Stocks Gain Tuesday Afternoon	MT
Jan. 06	European Equities Rise Tuesday; Anheuser-Busch to Reacquire US Metal Container Plants Stake	MT
Jan. 06	Swiss Market Index Bounces Back; Alcon Shares Gain	MT
Jan. 06	Staar Surgical to reject Alcon takeover bid after failing to win shareholder backing	RE
Jan. 06	Staar Surgical Shareholders Reject $1.6 Billion Acquisition by Alcon in Activist Win	DJ
Jan. 06	Staar Surgical did not receive votes to approve Alcon merger at special meeting of stockholders	RE
Jan. 06	STAAR Surgical Shareholders Reject Proposed Alcon Merger; Shares Fall	MT
Jan. 06	Staar Surgical to terminate merger agreement with Alcon	RE
Jan. 06	Deals of the day-Mergers and acquisitions	RE
Jan. 05	Alcon Research, LLC cancelled the acquisition of STAAR Surgical Company from a group of shareholders.	CI
Dec. 22	Broadwood Partners denounces STAAR Surgical's delay of shareholder vote on Alcon deal	RE
Dec. 19	Alcon Exercises Right to Require STAAR Surgical to Delay Stockholder Meeting	MT

Chart STAAR Surgical Company

Duration

Period

STAA: Dynamic Chart

Company Profile

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The Company is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The Company markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Companyâs EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.

Employees

1,157

Sector

Medical Equipment, Supplies & Distribution

Calendar

Feb. 24 - Q4 2025 Earnings Release (Projected)

More about the company